ALS Age of Onset, Risk Factors, and Early Signs

With amyotrophic lateral sclerosis (ALS), your voluntary muscles may begin to cause you problems. The early signs may be so minor you may overlook them. The age of onset for ALS is most often between 55 and 75.

Initial signs of ALS can vary from muscle twitches or stiffness to difficulty swallowing. But this is a progressive neurological disease that ultimately makes movement impossible. It is also known as Lou Gehrig's disease.

This article will discuss the age at which this condition usually strikes, what the earliest signs are likely to be, common risk factors, causes, how ALS progresses, and when to reach out for care.

A healthcare provider grasps the hand and touches shoulder of white-haired man

Pekic / Getty Images

ALS Age of Onset

While you can get ALS at any age, it usually affects those between 55 and 75. But one genetic form of ALS has been known to affect children as young as 4 years old. This particular form of ALS is caused by the gene SPTLC1, which affects the body's fat production.

Early Signs and Symptoms of ALS

The first symptoms of ALS may be subtle, and you may excuse or ignore them. Some of these early symptoms include the following:

You may suddenly have trouble buttoning your coat or signing your name. Problems can start in different parts of the body.

Bulbar onset is a type of ALS that causes problems with swallowing or speech. Frequently tripping or running awkwardly are signs of limb onset ALS.

Causes and Risk Factors

Unfortunately, most of the time, ALS occurs spontaneously without any apparent links to family history or genetic factors to explain it. This is called sporadic ALS.

But in up to 10% of cases, there can be a family connection. With familial ALS, there's a 50% likelihood that each child will inherit the mutation (change in genetic material) that may lead to the disease.

People who served in the military are somewhat more likely to develop ALS than those who haven't served. The Department of Veterans Affairs recognizes ALS as a service-related condition.

This may be due to the exposure to toxins released during warfare, environmental factors, or continually participating in highly strenuous activities. The latter may explain why professional athletes like National Football League players may be predisposed to this condition. ALS is commonly called Lou Gehrig's disease after the professional baseball player.


Genetics may play a role in ALS. In about two-thirds of cases in which ALS runs in families, a gene mutation can be identified. In fact, more than 25 genes may contribute to ALS.

Some of the key genes that may be implicated include the following:

  • The SOD1 gene mutation was the first detected (in 1993). It is thought to account for up to 20% of familial ALS cases and up to 2% of cases of sporadic ALS. Only one copy of the gene (from one parent) is enough to cause ALS when inherited. While the exact mechanism remains unclear, researchers think that the mutation causes the protein it produces to form clumps in motor neurons and astrocytes, leading to the death of these cells and ALS.
  • C9orf72, first discovered in 2011, is the most common genetic source of ALS, responsible for up to 40% of ALS cases that run in families and 7% of sporadic ones (cases that occur without a family history). Just one copy of the gene is needed to cause ALS.
  • NEK1 is a genetic mutation that accounts for 3% of all ALS cases. This is present in both instances that run in families as well as those that occur spontaneously.
  • TDP43 is found in 4% of familial cases and 1% of sporadic ones. Mutations in the TDP43 gene can cause the protein it produces to clump in motor neurons.
  • FUS (fused in sarcoma) was discovered in 2008. Just one copy of this dominant gene is needed to cause ALS. This causes 5% of familial cases and 1% of sporadic ones. This resembles TDP43, and likely plays a similar role in causing ALS.
  • KIF5A (kinesin family member 5A) was first detected in 2018. Just one copy of this gene is needed to cause ALS. Those with this mutation tend to survive longer than others with ALS, living on average for about 10 years after diagnosis.

Demographic Factors

While ALS can, unfortunately, affect anyone, some groups are more likely than others to develop the condition, including the following:

  • White males over age 60, without a family history of ALS, are most prone to the condition.
  • In the United States, Blacks are less likely than Whites to be diagnosed with ALS.
  • About 5% to 10% of people with ALS have a family history of this condition.
  • Higher concentrations of ALS appear in the U.S. Midwest and Northeast, areas where there is a high proportion of Whites.
  • The Western region of the United States has the lowest proportion of ALS cases, possibly due to the diversity of the population.
  • The slightly higher proportion of men vs. women wanes as people age.

Note that Verywell Health prefers to use inclusive terminology. But when citing health authorities and research, the terms relating to gender and sex from those sources are used.

Environmental Triggers

The environment that you live in also plays an important role. Here are some factors that are suspected to potentially trigger ALS:

  • Smoking
  • Beta-methylamino-l-alanine (BMAA), a naturally produced neurotoxin
  • Exposure to metals, radiation, solvents, and other toxins
  • Pesticides
  • Viruses (but none yet identified)
  • Military service
  • Intense exercise as part of your occupation

How ALS Progresses

ALS may start with minor issues such as difficulty fastening buttons or turning on the ignition in your car. This may seem perplexing at first. As the disease worsens, so do problems such as speaking, swallowing, moving, or breathing.

With time, weight loss may also become a problem. This occurs because those with ALS tend to burn calories more rapidly and they may also have difficulty chewing or swallowing.

ALS mainly affects physical functions. Most people with ALS maintain their reasoning abilities and understanding of how the condition affects them. A small percentage of people with ALS may also have difficulties with language or making decisions.

When to Seek Care

No test can quickly identify whether you have ALS. It takes nine months to two years for most people to be diagnosed with the condition. That's because it's easy to write off early mishaps as a product of aging.

Consult your healthcare provider as soon as you notice any signs of ALS. If your healthcare provider suspects ALS, they will likely refer you to a neurologist (a specialist in conditions affecting the central nervous system comprising the brain and spinal cord).

The drug Rilutek (riluzole) can help to slow symptom progression. If you have ALS, you will want to take this as early as possible. Relyvrio (sodium phenylbutyrate/taurursodiol) was approved by the Food and Drug Administration (FDA) in 2022 to slow the rate of decline in ALS.


ALS can strike anyone. The condition can begin with minor problems such as muscle twitches, stiffness, or cramping and can progress from there. Typically this affects those between ages 55 and 75, but in some cases, even young children can have this progressive neurological condition.

In many cases, ALS can occur without obvious cause, but in some, there can be a hereditary connection. More than 25 genes associated with ALS have been identified. Environmental factors may have a role in ALS development.

Frequently Asked Questions

  • Who has the highest risk of developing ALS?

    Those most likely to get ALS are non-Hispanic Whites between ages 55 and 75. Also, ALS is 1.5 to 2 times more prevalent in military veterans. If you have a family member with ALS, you may also be at higher risk since about 5% to 10% of cases are familial, and it can be inherited from one parent.

  • What are the odds of developing ALS?

    For those with no family history, there's a lifetime risk of this affecting about 1 in 400 people. This condition tends to be rare before age 40 and becomes much more prevalent with age. Some studies have found that with familial ALS, individuals have a threefold to tenfold greater risk of developing the condition.

  • Can you have ALS for years without knowing it?

    It can be easy to discount early symptoms. Studies from various countries have found a delay of around a year from symptom onset to diagnosis. There is, unfortunately, no clear-cut test to make the diagnosis.

15 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. National Institute of Neurological Disorders and Stroke. Amyotrophic lateral sclerosis (ALS) fact sheet.

  2. Daneshvar DH, Mez J, Alosco ML, et al. Incidence of and mortality from amyotrophic lateral sclerosis in National Football League athletes. JAMA Netw Open. 2021;4(12):e2138801. doi:10.1001/jamanetworkopen.2021.38801

  3. ALS Association. The genetics of ALS.

  4. Centers for Disease Control and Prevention. Prevalence of amyotrophic lateral sclerosis.

  5. ALS Association. Environmental factors.

  6. Cucovici A, Fontana A, Ivashynka A, et al. The impact of lifetime alcohol and cigarette smoking loads on amyotrophic lateral sclerosis progression: a cross-sectional study. Life (Basel). 2021;11(4):352. doi:10.3390/life11040352

  7. Proctor EA, Mowrey DD, Dokholyan NV. β-Methylamino-L-alanine substitution of serine in SOD1 suggests a direct role in ALS etiology. PLoS Comput Biol. 2019;15(7):e1007225. doi:10.1371/journal.pcbi.1007225

  8. Andrew A, Zhou J, Gui J, et al. Pesticides applied to crops and amyotrophic lateral sclerosis risk in the U.S. Neurotoxicology. 2021;87:128-135. doi:10.1016/j.neuro.2021.09.004

  9. Castanedo-Vazquez D, Bosque-Varela P, Sainz-Pelayo A, Riancho J. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration. J Neurol. 2019;266(1):27-36. doi:10.1007/s00415-018-8919-3

  10. Tai H, Cui L, Shen D, Li D, Cui B, Fang J. Military service and the risk of amyotrophic lateral sclerosis: A meta-analysis. J Clin Neurosci. 2017;45:337-342. doi:10.1016/j.jocn.2017.08.035

  11. Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771-776. doi:10.1097/WCO.0000000000000730

  12. ALS Association. Obtaining an ALS diagnosis.

  13. Food and Drug Administration. FDA approves new treatment option for patients with ALS.

  14. Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76(11):1367-1374. doi:10.1001/jamaneurol.2019.2044

  15. Ingre C, Roos PM, Piehl F, Kamel F, Fang F. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181-93. doi:10.2147/CLEP.S37505

By Maxine Lipner
Maxine Lipner is a long-time health and medical writer with over 30 years of experience covering ophthalmology, oncology, and general health and wellness.